This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Tandem Diabetes Care, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Pat Mulvihill: Innovator in Diabetes Management
Introduction
Pat Mulvihill is a notable inventor based in San Diego, CA, who has made significant contributions to the field of diabetes management. His innovative work focuses on improving automated insulin delivery systems, which are crucial for individuals managing diabetes.
Latest Patents
Pat Mulvihill holds a patent for "Systems and methods for delayed meal boluses in automated insulin delivery." This patent discloses apparatuses and methods that provide a delayed bolus calculator for use in closed-loop diabetes therapy. The invention accounts for additional factors not considered in regular meal bolus calculations, allowing users to deliver a meal bolus after a meal has been consumed. The delayed bolus calculator enables users to input the time since the meal and the number of carbohydrates consumed, ensuring that the risk of hypoglycemia is mitigated while still reducing hyperglycemia.
Career Highlights
Pat Mulvihill is associated with Tandem Diabetes Care, Inc., a company dedicated to developing innovative diabetes management solutions. His work has been instrumental in advancing technology that supports individuals with diabetes in managing their condition more effectively.
Collaborations
Throughout his career, Pat has collaborated with talented individuals such as Nicholas Sherer and Thomas R Ulrich. These collaborations have contributed to the development of cutting-edge solutions in diabetes care.
Conclusion
Pat Mulvihill's contributions to diabetes management through his innovative patent demonstrate his commitment to improving the lives of those living with diabetes. His work continues to pave the way for advancements in automated insulin delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
